The Role of PET with [18-F] Fluorodeoxyglucose in the Diagnosis and Management of Thoracic Vascular Disease.
Investigating the functional activity of cellular inflammatory mediators is fundamental to understanding the pathophysiology and improving the treatment of numerous vascular conditions. PET with FDG allows noninvasive in vivo assessment of inflammatory vascular processes and may be coupled to CT or MRI to provide simultaneous anatomic information. These unique properties have provided additional insight into the pathophysiology, diagnosis, and management of thoracic vascular diseases. In this article, the role of FDG-PET in the assessment of thoracic vascular disease and the influence of this technique on the diagnostic and management approaches are discussed.